De-shen Wang

De-shen Wang

Sun Yat-Sen University

H-index: 39

Asia-China

About De-shen Wang

De-shen Wang, With an exceptional h-index of 39 and a recent h-index of 32 (since 2020), a distinguished researcher at Sun Yat-Sen University, specializes in the field of GI medical oncologist.

His recent articles reflect a diverse array of research interests and contributions to the field:

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases

Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer

Deep learning-derived spatial organization features on histology images predicts prognosis in colorectal liver metastasis patients after hepatectomy

Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells

Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A …

The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors

De-shen Wang Information

University

Position

Cancer Center

Citations(all)

5634

Citations(since 2020)

4086

Cited By

2699

hIndex(all)

39

hIndex(since 2020)

32

i10Index(all)

80

i10Index(since 2020)

69

Email

University Profile Page

Sun Yat-Sen University

Google Scholar

View Google Scholar Profile

De-shen Wang Skills & Research Interests

GI medical oncologist

Top articles of De-shen Wang

Title

Journal

Author(s)

Publication Date

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Nature Medicine

Feng Wang

Ying Jin

Min Wang

Hui-Yan Luo

Wei-Jia Fang

...

2024/3/4

Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases

Therapeutic Advances in Medical Oncology

Zhi-Gang Chen

Xiao-Meng Ji

Yu-Xia Xu

William Pat Fong

Xiao-Yun Liu

...

2024/2

Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer

Therapeutic Advances in Medical Oncology

Zi-Yao Huang

Lei Wen

Liu-Fang Ye

Yu-Ting Lu

William Pat Fong

...

2024/1

Deep learning-derived spatial organization features on histology images predicts prognosis in colorectal liver metastasis patients after hepatectomy

Iscience

Lin Qi

Jie-ying Liang

Zhong-wu Li

Shao-yan Xi

Yu-ni Lai

...

2023/10/20

Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells

Clinical and Translational Medicine

Jiaojiao Yang

Liyue Sun

Xiao‐Yun Liu

Chan Huang

Junling Peng

...

2023/9

Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A …

Yu-hong Li

De-Shen Wang

Yang-Kui Gu

Lei Wen

Chao Ren

...

2023/6/1

The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Cancer Research

Jia Liu

Ze-Xian Liu

Jia-Jun Li

Zhao-Lei Zeng

Jin-Hong Wang

...

2023/5/2

Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors

Nature Communications

Renjing Zhang

Yang Yang

Chunfang Hu

Mayan Huang

Wenjian Cen

...

2023/11/18

Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma

Cell Reports Medicine

Yang Zhang

Miao-Zhen Qiu

Ju-Feng Wang

Yan-Qiao Zhang

Ao Shen

...

2022/11/15

Effect of induction chemotherapy with paclitaxel, cisplatin, and capecitabine vs cisplatin and fluorouracil on failure-free survival for patients with stage IVA to IVB …

JAMA oncology

Wang-Zhong Li

Xing Lv

Dan Hu

Shu-Hui Lv

Guo-Ying Liu

...

2022/5/1

Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma

Gastric Cancer

Wei Wang

Liu-Fang Ye

Hua Bao

Ming-Tao Hu

Ming Han

...

2022/11

Effect of capecitabine maintenance therapy plus best supportive care vs best supportive care alone on progression-free survival among patients with newly diagnosed metastatic …

JAMA oncology

Guo-Ying Liu

Wang-Zhong Li

De-Shen Wang

Hu Liang

Xing Lv

...

2022/4/1

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment

Gut

Feng Wang

You-Sheng Huang

Hao-Xiang Wu

Zi-Xian Wang

Ying Jin

...

2022/7/1

Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation

Journal for Immunotherapy of Cancer

Lei Wen

Zhigang Chen

Xiaomeng Ji

William Pat Fong

Qiong Shao

...

2022

ASO Visual Abstract: Circulating Lipid-and Inflammation-Based Risk (CLIR) Score—A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection

Annals of Surgical Oncology

Long Bai

Xiao-Luan Yan

Yun-Xin Lu

Qi Meng

Yu-Ming Rong

...

2022/7/1

Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer

Oncoimmunology

Jia Bo Zheng

Chau Wei Wong

Jia Liu

Xiao-Jing Luo

Wei-Yi Zhou

...

2022/12/31

Circulating Lipid-and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection

Annals of Surgical Oncology

Long Bai

Xiao-Luan Yan

Yun-Xin Lu

Qi Meng

Yu-Ming Rong

...

2022/7

Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA

Drug Resistance Updates

Liu-Fang Ye

Zi-Yao Huang

Xiao-Xi Chen

Zhi-Gang Chen

Si-Xian Wu

...

2022/12/1

Endoscopic excision as a viable alternative to major resection for early duodenal cancers: a population-based cohort study

International Journal of Surgery

Yongqiang Zheng

Pengcheng Yang

Jiayuan Chen

Kai Yu

Yuzhong Ye

...

2022/5/1

The prognostic value of locoregional interventions for BRAF V600E metastatic colorectal cancer: a retrospective cohort analysis

Biomolecules

Liu-Fang Ye

Xiao-Meng Ji

Chao Ren

Zhi-Qiang Wang

Chun-Ping Lin

...

2021/8/25

See List of Professors in De-shen Wang University(Sun Yat-Sen University)

Co-Authors

H-index: 82
Zhe-Sheng Chen

Zhe-Sheng Chen

St. John's University

H-index: 51
Jarvis T. Chen

Jarvis T. Chen

Harvard University

H-index: 45
Zhixiang Zuo (左志向)

Zhixiang Zuo (左志向)

Sun Yat-Sen University

H-index: 39
Dong-Hua Yang

Dong-Hua Yang

St. John's University

academic-engine